SGBI
vs
S&P 500
SGBI
S&P 500
Over the past 12 months, SGBI has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +12% growth.
Stocks Performance
SGBI vs S&P 500
Performance Gap
SGBI vs S&P 500
Performance By Year
SGBI vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sangui Biotech International Inc
Glance View
Sangui BioTech International, Inc. is a holding company, which engages in the research, development, manufacturing, and sales of medical and cosmetic products. The company is headquartered in Hamburg, Hamburg. The firm develops its products through its German subsidiary, SanguiBioTech AG (Sangui GmbH). The company is engaged in seeking to market and selling its products through partnerships with industry partners across the world. The company focuses on the development of oxygen carriers capable of providing oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia or blood loss whether due to surgery, trauma, or other causes. The company focuses its development and commercialization efforts on such artificial oxygen carriers by reproducing and synthesizing polymers out of native hemoglobin of defined molecular sizes. The company offers external applications of oxygen transporters in the medical and cosmetic fields in the form of sprays for the healing of chronic wounds and of gels and emulsions for the regeneration of the skin.
